Navina secures $15 million Series A for AI primary care platform
The Israeli startup uses medically-informed artificial intelligence to replace disorganized patient data with a logical grid to assist primary care physicians in making complex decisions
Israeli startup Navina, which has developed an AI-powered clinical platform for primary care, announced on Monday that it has secured $15 million in Series A funding led by Vertex Ventures Israel. Schusterman Family Investments (SFI) and existing investor Grove Ventures also joined the round. This brings the company’s total funding to date to $22 million, raised within 12 months after commercial launch.
Navina uses medically-informed AI to replace disorganized patient data with a Patient Portrait - a logical grid that makes it possible for every primary care physician to assess complex cases in minutes. Until now primary care physicians have had limited tools to effectively absorb point of care data for a quick understanding of their patients.
Navina co-founders Perera (right) and Ronen Lavi. Photo: David Garb, courtesy of Grove Ventures
"We started Navina to help physicians make the most of all the digital data that is overwhelming them,” said Ronen Lavi, co-founder and CEO of Navina. “Navina delivers deep patient understanding in a quick view, and will become core to every physician-patient interaction. As new sources of patient data emerge, telehealth grows in its acceptance and COVID continues to pressure physicians, Navina will become indispensable to relieving their stress and supporting more responsive patient care.”
“We are excited to lead Navina’s new round of financing”, said Emanuel Timor, General Partner at Vertex Ventures. “The company is solving a major problem for primary care physicians, who occupy a critical role at medicine's front lines. It provides instant access to the data they need for proactive and empathetic care in the community. Physician adoption and high levels of usage demonstrate that Navina is filling this essential role. The company is led by an exceptionally talented and devoted team that blends deep technical and medical expertise. We believe that it combines the rapid scalability of a SaaS company with a transformative impact of a true healthcare disruptor.”